The estimated Net Worth of Geoffrey E. Harris is at least $575 Tisíc dollars as of 14 January 2019. Mr. Harris owns over 100,000 units of Cancer Genetics stock worth over $575,025 and over the last 10 years he sold CGIX stock worth over $0. In addition, he makes $0 as Director at Cancer Genetics.
Sign up
Mr. Harris CGIX stock SEC Form 4 insiders trading
Geoffrey has made over 6 trades of the Cancer Genetics stock since 2015, according to the Form 4 filled with the SEC. Most recently he bought 100,000 units of CGIX stock worth $23,000 on 14 January 2019.
The largest trade he's ever made was buying 100,000 units of Cancer Genetics stock on 14 January 2019 worth over $23,000. On average, Geoffrey trades about 9,196 units every 103 days since 2014. As of 14 January 2019 he still owns at least 127,500 units of Cancer Genetics stock.
You can see the complete history of Mr. Harris stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Geoffrey Harris biography
Geoffrey Eric Harris is the Director of the Company. He served as a managing director and co-head of the healthcare investment banking group at Cantor Fitzgerald, and from 2009-2011, he held a similar position at Gleacher & Company. Mr. Harris is also currently on the board of directors of GoNow Doctors (Nasdaq:ANCI), a healthcare services company, MYnd Analytics (Nasdaq: CNSO), a data analysis company focused on improving mental health care, Amperic, Inc., a privately-held technology company, and PointRight Inc., a privately-held software company. Mr. Harris graduated from MIT's Sloan School of Management with an M.S. in Finance Management.
How old is Geoffrey Harris?
Geoffrey Harris is 56, he's been the Director of Cancer Genetics since 2016. There are 6 older and 1 younger executives at Cancer Genetics. The oldest executive at Cancer Genetics Inc. is John Pappajohn, 90, who is the Non-Executive Chairman of the Board.
What's Geoffrey Harris's mailing address?
Geoffrey's mailing address filed with the SEC is 201 NJ-17, Rutherford, NJ 07070, USA.
Insiders trading at Cancer Genetics
Over the last 12 years, insiders at Cancer Genetics have traded over $1,720,897 worth of Cancer Genetics stock and bought 3,891,559 units worth $4,573,241 . The most active insiders traders include John Pappajohn, Tommy G Thompson a John A Roberts. On average, Cancer Genetics executives and independent directors trade stock every 35 days with the average trade being worth of $340,207. The most recent stock trade was executed by John A Roberts on 31 January 2019, trading 185,436 units of CGIX stock currently worth $42,650.
What does Cancer Genetics's logo look like?
Complete history of Mr. Harris stock trades at Cancer Genetics
Cancer Genetics executives and stock owners
Cancer Genetics executives and other stock owners filed with the SEC include:
-
Jane Houldsworth,
Vice President - Research & Development -
Franklyn Prendergast,
Independent Director -
Howard McLeod,
Independent Director -
Edmund Cannon,
Independent Director -
Thomas Widmann,
Director -
Geoffrey Harris,
Director -
John Roberts,
President, Chief Executive Officer, Principal Financial Officer and Principal Accounting Officer -
John Pappajohn,
Non-Executive Chairman of the Board -
Panna Sharma,
Chief Executive Officer -
Raju S.K. Chaganti,
Director -
Michael J. Welsh,
Director -
Edward J Sitar,
Chief Financial Officer -
Igor Gitelman,
Chief Accounting Officer -
Michael Brian Mc Cartney,
Chief Commercial Officer -
Michael Glenn Miles,
Chief Financial Officer -
Ralf Brandt,
President, Discovery Services -
Rita Shaknovich,
VP of Hematopathology Services -
Paul Rothman,
Director -
Keith L Brownlie,
Director -
Andrew L Pecora,
Director -
Tommy G Thompson,
Director -
Steven Hepburn,
VP of Biopharma Marketing